Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Genetic testing and surgeon decision.

¹Sezione di Genetica Medica DI.M.I.M.P. Universit di Bari, Italia.

Acta Chirurgica Iugoslavica

|March 18, 2005

Summary

Mutant or overexpressed p53 protein in colon cancer is linked to a poorer prognosis. Identifying such biomarkers may improve targeted colorectal cancer treatments for individual patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bradykinin stimulation does not induce intracellular Ca2+ elevation in cells from desmoid tumors.

Oncology reports·2011

Same author

Noncolonic cancer stem cells in bone marrow of colorectal cancer patients.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2009

Same author

The Italian external quality assessment scheme in classical cytogenetics: four years of activity.

Community genetics·2008

Same author

Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.

Current pharmaceutical design·2008

Same author

Novel splice isoforms of STRADalpha differentially affect LKB1 activity, complex assembly and subcellular localization.

Cancer biology & therapy·2007

Same author

Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.

Clinical genetics·2007

Area of Science:

Oncology
Cancer Genetics

Background:

Colorectal cancer (CRC) is curable when localized.
Traditional staging is insufficient due to CRC's heterogeneity.
Genetic alterations drive CRC progression from adenoma to metastasis.

Purpose of the Study:

To identify reliable biomarkers for precise therapeutic decisions in CRC.
To investigate the prognostic value of p53 in locally advanced colon cancer.

Main Methods:

Utilized monoclonal antibodies (PAB 1801/DO-7/D0-1) targeting p53.
Studied cohorts of at least 100 patients with locally advanced colon cancer.

Main Results:

Mutant or overexpressed p53 was associated with a worse clinical outcome.
p53 alterations correlate with disease progression and prognosis.

Conclusions:

p53 status serves as a potential prognostic marker in colon cancer.
Targeting therapies based on p53 expression may enhance patient outcomes.

Related Experiment Videos